The data exclusivity period applicable to pharmaceuticals for human use is to be extended by the introduction of an 8+2+1 rule to replace the current 6-year exclusivity period.

Products which are not registered as medicines may not be advertised as having medicinal properties, according to a decision of the Chief Pharmaceutical Inspector.

The sale of popular drinks containing taurine and caffeine, commonly referred to as "energy drinks", has been limited from 1 January 2024 in accordance with provisions introduced in the Act of 17...

The act will come into force 30 days after its publication in the Journal of Laws.

The Chief Pharmaceutical Inspector is entitled to supervise all pharmaceutical trade in Poland, including trade by companies based outside Poland, according to the Voivodship Administrative Court in Warsaw.

New laws governing the reimbursement of medicines, medical devices and foodstuffs for special medical purposes have been signed by the President.

The European Commission has approved a PLN 40.5 million (c. €10 million) loan from Poland for the restructuring of Tarchominskie Zakłady Farmaceutyczne "POLFA" S.A.

From 1 January 2012, doctors will only be able to obtain a medicinal product sample for 2 years after first requesting it, and will be limited to a maximum of 4 samples per year.

Significant proposed changes to pharmaceutical advertising are included in the ‘health pack’ currently being considered in Parliament.

The procedures for setting prices and applying for reimbursement of pharmaceuticals and medical devices is to be fundamentally changed.

On 12 July 2017, a new act on counteracting the unfair use of contractual advantage in trade in agricultural and food products (the "Act") will enter into force in Poland.

One year has passed since the Act on Counteracting the Unfair Use of Contractual Advantage in the Trade of Agricultural and Food Products entered into force.

The pharmaceutical market in Poland has significantly developed during the last decades making it attractive for investors.

Artificial intelligence (AI) and molecular modeling (MM) are now being increasingly used to design innovative drugs.

In preparation for situations of crisis caused by a potential spread of the coronavirus, the Polish Parliament has adopted a draft bill that introduces certain new obligations upon...

The Act of 15 December 2016 on Counteracting Unfair Use of Contractual Advantage in Trade of Agricultural and Food Products came into force and effect on 12 July 2017.

Oświadczenia żywieniowe w Unii Europejskiej są regulowane przez Rozporządzenie (WE) nr 1924/2006 w sprawie oświadczeń żywieniowych i zdrowotnych dotyczących żywności.

For pharmaceutical industry companies, each day of market monopoly enjoyed thanks to a patent means some handsome profits.

Patent protection plays a key role in shaping the pharmaceutical market, affecting the availability of medicines, innovation in the design of new medicinal products as well as the development...

Today's food industry faces many challenges in ensuring food safety, quality and sustainability. As the demand for safe, healthy and organic food continues...